...
【24h】

Genomic sequencing and precision medicine in head and neck cancers

机译:头部和颈部癌症的基因组测序和精密药物

获取原文
获取原文并翻译 | 示例

摘要

Head and neck squamous cell carcinoma (HNSCC) remains a common and deadly disease. Historically, surgical and chemoradiation treatments have been met with modest success, and understanding of genetic drivers of HNSCC has been limited. With recent next generation sequencing studies focused on HNSCC, we are beginning to understand the genetic landscape of HNSCCs and are starting to identify and advance targeted options for patients. In this review, we describe current knowledge and recent advances in sequencing studies of HNSCC, discuss current limitations and future directions for further genomic analysis, and highlight the translational advances being undertaken to treat this important disease. (C) 2016 Elsevier Ltd, BASO The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
机译:头部和颈部鳞状细胞癌(HNSCC)仍然是常见和致命的疾病。 从历史上看,已经满足了手术和化学地理治疗的谦虚成功,并且了解HNSCC的遗传驱动因素受到限制。 随着近期专注于HNSCC的下一代测序研究,我们开始了解HTNSCCS的遗传景观,并开始识别和提前针对患者的靶向选择。 在本综述中,我们描述了当前的知识和最近在HNSCC测序研究方面的进步,讨论了进一步的基因组分析的当前限制和未来方向,并突出了治疗这一重要疾病的翻译进展。 (c)2016年Elsevier Ltd,Baso癌症手术协会,以及欧洲外科肿瘤学会。 版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号